About 12% of Americans aged 14 to 49 have genital herpes caused by HSV-2, the virus most commonly associated with the condition. That translates to roughly one in eight people in that age group. Globally, the number is even higher: an estimated 520 million people aged 15 to 49, or about 13% of the world’s population in that range, are living with HSV-2.
Those numbers only capture part of the picture. A growing share of genital herpes cases are now caused by HSV-1, the virus traditionally linked to cold sores, which means the true percentage of people with genital herpes of any type is higher than HSV-2 statistics alone suggest.
U.S. Prevalence by Sex and Age
CDC data from 2015 to 2016 found the age-adjusted prevalence of HSV-2 among 14- to 49-year-olds was 12.1% overall. Women are nearly twice as likely to carry the virus: 15.9% of females tested positive compared to 8.2% of males. This gap is consistent across every survey period the CDC has tracked and reflects a biological reality. HSV-2 transmits more efficiently from men to women during sex than the reverse, largely because mucosal tissue in the vaginal and cervical lining is more susceptible to infection.
Prevalence also rises sharply with age. Teenagers and young adults in their early twenties have significantly lower rates than adults in their 30s and 40s, simply because more years of sexual activity means more cumulative exposure.
HSV-1 Is Changing the Numbers
Genital herpes isn’t caused by a single virus. A 2023 meta-analysis found that roughly 37% of genital herpes cases are now attributed to HSV-1, with the remaining 62% caused by HSV-2. This shift has been driven by declining rates of childhood oral HSV-1 infection in wealthier countries. When people aren’t exposed to HSV-1 as children (through kissing or shared utensils), they reach adulthood without any immunity to it. If they then encounter HSV-1 through oral sex, the virus can establish itself genitally.
Because standard prevalence surveys typically measure only HSV-2 antibodies, the 12% figure underestimates how many people actually have genital herpes. There’s no easy way to determine from a blood test alone whether someone’s HSV-1 infection is oral, genital, or both.
Most People Don’t Know They Have It
The majority of people carrying HSV-2 have never been diagnosed. Many experience no recognizable symptoms, or their symptoms are mild enough to be mistaken for something else: a small bump, a patch of irritation, a brief itch that resolves on its own. This is a major reason the virus spreads so effectively.
Even without symptoms, the virus periodically reactivates and reaches the skin’s surface. A study tracking daily genital swabs found that people with no history of symptoms still shed the virus on about 10% of days. Those with recognized outbreaks shed on about 20% of days. Among people who never noticed symptoms, a striking 84% of their shedding episodes were completely silent, with no visible sores or discomfort at all.
How Transmission Works in Practice
Genital herpes spreads through direct skin-to-skin contact with an infected area, whether or not a sore is visible. The virus can transmit during vaginal, anal, or oral sex. Because shedding happens unpredictably between outbreaks, there is no completely “safe” window based on symptoms alone.
Condoms reduce the risk substantially, though their effectiveness differs by direction of transmission. One study of couples where one partner had HSV-2 found that consistent condom use reduced per-act transmission from men to women by 96%. Protection from women to men was lower, around 65%, likely because condoms don’t cover all potentially shedding skin in the female genital area. Daily antiviral medication further reduces transmission risk and can be combined with condoms for greater protection.
Testing and Its Limitations
If you suspect exposure, two main testing approaches exist. A swab test, taken directly from an active sore, can confirm the virus and identify the type. This is the most reliable method but requires a visible lesion.
Blood tests detect antibodies rather than the virus itself, and their accuracy varies. For HSV-2, the most widely used tests have sensitivity above 97% and specificity above 98%, meaning false results are uncommon but not impossible. HSV-1 blood tests are less reliable, with some assays dropping below 85% sensitivity. A positive HSV-1 blood test also can’t distinguish between an oral and a genital infection, which limits its usefulness for someone trying to understand their genital herpes status specifically.
Routine herpes screening is not included in standard STI panels in the United States. The CDC does not recommend universal screening for people without symptoms, partly because of the psychological burden of diagnosis in the context of a virus that most carriers never notice, and partly because of the limitations of blood testing. If you want to be tested, you typically need to request it.
Why the Real Number Is Likely Higher
The 12% figure is a floor, not a ceiling. It counts only HSV-2 in a specific age range, misses genital HSV-1 entirely, and relies on a survey sample that may not capture every demographic equally. When you factor in the growing proportion of genital cases caused by HSV-1, the millions of undiagnosed carriers, and the people over 49 who aren’t included in the standard age bracket, the actual percentage of adults who have or have had genital herpes is almost certainly higher than one in eight.
The practical takeaway is that genital herpes is one of the most common sexually transmitted infections in the world. Most people who have it don’t know, most who know manage it without major disruption to their lives, and the stigma surrounding it is wildly disproportionate to its medical impact.